Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Jasmina KapetanovicDr Jasmina Kapetanovic has been awarded an MRC Clinician Scientist Fellowship, for her research: 'New genetic therapy approaches for inherited retinal diseases.' The award will support her research on optimising the delivery and expression of genes in retinal disorders using latest technologies.

The focus of her research has been to use pre-clinical models to develop new treatments for inherited retinal degenerations, the commonest cause of blindness in working age population. One of the main obstacles in translating retinal genetic therapies is low efficiency of retinal vector transduction. To address this, the fellowship programme will develop innovative delivery strategies using robotic assistance to improve targeting of retinal neurons with gene therapy vectors. The project will also focus on optimising gene expression in mitochondria, for the treatment of optic neuropathies, and in inner retinal neurons for optogenetic applications to restore vision.

The MRC fellowship will allow her to establish her independent research programme within the Clinical Ophthalmology Research Group, and develop new treatments that can be applied directly to patients to prevent and restore sight loss.

Similar stories

New insights into the effect of exposure to dim light in the evening on the biology of the sleep-wake cycle

A new study has revealed more about how exposure to dim light in the evening affects circadian health. The findings emphasise the need to optimise our artificial light exposure if we are to avoid shifting our biological clocks.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic

Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.